Table 3. Correlation between HOMA-IR and Muscle Attenuation.
| HOMA-IR | ||
|---|---|---|
| β (SE) | p value | |
| Gluteus maximus muscle attenuation | −0.194 (0.013) | 0.018 |
| Model 1 | −0.204 (0.013) | 0.016 |
| Model 2 | −0.212 (0.012) | 0.008 |
| Model 3 | −0.199 (0.013) | 0.013 |
| Quadriceps muscle attenuation | −0.292 (0.021) | <0.001 |
| Model 1 | −0.295 (0.021) | <0.001 |
| Model 2 | −0.278 (0.020) | <0.001 |
| Model 3 | −0.230 (0.021) | 0.004 |
HOMA-IR, homeostatic model assessment-insulin resistance; BMI, body mass index; eGFR, estimated glomerular filtration rate; SERM, selective estrogen receptor modulators; AST, aspartate transaminase; ALT, alanine transaminase; BMD, bone mineral density.
Model 1 adjusted for age and BMI; model 2 adjusted for model 1 parameters+eGFR, AST, ALT and total cholesterol; model 3 adjusted for model 2 parameters+hip BMD, physical activity (exercise/week), medication history (SERM, metformin or thiazolidinediones), smoking history and fracture history.